Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Elephantiasis, Filarial | 3 | 2019 | 47 | 0.55 | Why? |
| Wuchereria bancrofti | 2 | 2019 | 13 | 0.40 | Why? |
| Diethylcarbamazine | 2 | 2018 | 11 | 0.24 | Why? |
| Albendazole | 2 | 2018 | 32 | 0.24 | Why? |
| Bone Marrow Cells | 1 | 2021 | 186 | 0.20 | Why? |
| Loiasis | 1 | 2019 | 7 | 0.20 | Why? |
| DNA, Mitochondrial | 1 | 2021 | 163 | 0.20 | Why? |
| Topography, Medical | 1 | 2019 | 45 | 0.19 | Why? |
| Filaricides | 1 | 2018 | 41 | 0.19 | Why? |
| Hip Dislocation, Congenital | 1 | 2018 | 9 | 0.19 | Why? |
| Acetabulum | 1 | 2018 | 18 | 0.18 | Why? |
| Osteotomy | 1 | 2018 | 30 | 0.18 | Why? |
| Plasma Cells | 1 | 2021 | 464 | 0.18 | Why? |
| Cell-Free Nucleic Acids | 1 | 2021 | 271 | 0.17 | Why? |
| Technology, Pharmaceutical | 1 | 2017 | 82 | 0.16 | Why? |
| Chemistry, Pharmaceutical | 1 | 2017 | 152 | 0.16 | Why? |
| Survivorship | 1 | 2018 | 106 | 0.16 | Why? |
| Genetics, Medical | 1 | 2017 | 64 | 0.16 | Why? |
| Exome | 1 | 2017 | 207 | 0.15 | Why? |
| Endemic Diseases | 1 | 2019 | 480 | 0.14 | Why? |
| Whole Exome Sequencing | 1 | 2017 | 437 | 0.14 | Why? |
| Genetic Testing | 1 | 2017 | 395 | 0.13 | Why? |
| Expert Testimony | 1 | 2017 | 658 | 0.12 | Why? |
| Patient Reported Outcome Measures | 1 | 2018 | 912 | 0.11 | Why? |
| Plasma | 1 | 2021 | 1809 | 0.11 | Why? |
| Reagent Kits, Diagnostic | 1 | 2021 | 2149 | 0.11 | Why? |
| Ivermectin | 1 | 2018 | 973 | 0.09 | Why? |
| Immunoassay | 2 | 2021 | 4485 | 0.09 | Why? |
| Electronic Health Records | 1 | 2021 | 3492 | 0.09 | Why? |
| Burnout, Professional | 2 | 2021 | 2489 | 0.09 | Why? |
| Education, Medical, Graduate | 1 | 2021 | 2082 | 0.08 | Why? |
| Education, Medical | 1 | 2021 | 2461 | 0.07 | Why? |
| Physicians | 2 | 2021 | 4214 | 0.07 | Why? |
| Asthma | 1 | 2021 | 4383 | 0.06 | Why? |
| Coinfection | 1 | 2021 | 6820 | 0.05 | Why? |
| Stress, Psychological | 2 | 2021 | 10231 | 0.05 | Why? |
| Internship and Residency | 1 | 2021 | 4987 | 0.05 | Why? |
| Microfilariae | 1 | 2018 | 5 | 0.05 | Why? |
| Parasite Load | 1 | 2018 | 15 | 0.05 | Why? |
| Antigens, Protozoan | 1 | 2019 | 121 | 0.05 | Why? |
| Antibodies, Helminth | 1 | 2018 | 48 | 0.05 | Why? |
| ROC Curve | 2 | 2021 | 6024 | 0.05 | Why? |
| Antibodies, Protozoan | 1 | 2019 | 121 | 0.05 | Why? |
| Severity of Illness Index | 3 | 2021 | 48226 | 0.05 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.05 | Why? |
| Culex | 1 | 2018 | 66 | 0.04 | Why? |
| Sri Lanka | 1 | 2018 | 241 | 0.04 | Why? |
| Anthelmintics | 1 | 2018 | 104 | 0.04 | Why? |
| Cameroon | 1 | 2019 | 464 | 0.04 | Why? |
| Mass Drug Administration | 1 | 2018 | 143 | 0.04 | Why? |
| Missouri | 1 | 2018 | 274 | 0.04 | Why? |
| Vasoconstrictor Agents | 1 | 2021 | 714 | 0.04 | Why? |
| Microscopy, Electron, Scanning | 1 | 2017 | 221 | 0.04 | Why? |
| Metabolome | 1 | 2021 | 624 | 0.04 | Why? |
| Crystallization | 1 | 2017 | 331 | 0.04 | Why? |
| Adult | 11 | 2021 | 244371 | 0.04 | Why? |
| Genetic Diseases, Inborn | 1 | 2017 | 190 | 0.04 | Why? |
| Cell Survival | 1 | 2021 | 1581 | 0.04 | Why? |
| Metabolomics | 1 | 2021 | 921 | 0.04 | Why? |
| Male | 12 | 2021 | 367725 | 0.04 | Why? |
| Pain Measurement | 1 | 2018 | 533 | 0.03 | Why? |
| Single-Blind Method | 1 | 2018 | 1283 | 0.03 | Why? |
| Female | 12 | 2021 | 380317 | 0.03 | Why? |
| Mental Health | 1 | 2021 | 15770 | 0.03 | Why? |
| Genetic Counseling | 1 | 2017 | 229 | 0.03 | Why? |
| Disability Evaluation | 1 | 2018 | 671 | 0.03 | Why? |
| Patient Acuity | 1 | 2021 | 1755 | 0.03 | Why? |
| Young Adult | 6 | 2021 | 93724 | 0.03 | Why? |
| Linear Models | 1 | 2020 | 1914 | 0.03 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.03 | Why? |
| Arthroplasty, Replacement, Hip | 1 | 2018 | 403 | 0.03 | Why? |
| Particle Size | 1 | 2017 | 1052 | 0.03 | Why? |
| Africa | 1 | 2021 | 2986 | 0.03 | Why? |
| Renal Replacement Therapy | 1 | 2021 | 1530 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2018 | 2324 | 0.03 | Why? |
| Adolescent | 5 | 2019 | 86841 | 0.03 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.03 | Why? |
| Humans | 14 | 2021 | 930598 | 0.02 | Why? |
| Immunologic Memory | 1 | 2021 | 3362 | 0.02 | Why? |
| Child | 4 | 2019 | 70012 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2018 | 4260 | 0.02 | Why? |
| Biomarkers | 2 | 2021 | 23361 | 0.02 | Why? |
| Disease Susceptibility | 1 | 2021 | 4002 | 0.02 | Why? |
| Diagnostic Tests, Routine | 1 | 2019 | 2643 | 0.02 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.02 | Why? |
| Aged | 5 | 2021 | 215776 | 0.02 | Why? |
| Risk Factors | 3 | 2021 | 71621 | 0.02 | Why? |
| Prevalence | 2 | 2019 | 25773 | 0.02 | Why? |
| Rural Population | 1 | 2019 | 2408 | 0.02 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 7868 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2021 | 9893 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.02 | Why? |
| Immunization, Passive | 1 | 2021 | 10067 | 0.02 | Why? |
| Animals | 3 | 2019 | 78931 | 0.02 | Why? |
| Machine Learning | 1 | 2021 | 4395 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2018 | 7268 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2021 | 9091 | 0.02 | Why? |
| Surveys and Questionnaires | 2 | 2021 | 43792 | 0.02 | Why? |
| Pharmaceutical Preparations | 1 | 2017 | 1897 | 0.02 | Why? |
| Retrospective Studies | 3 | 2021 | 105322 | 0.02 | Why? |
| Treatment Outcome | 2 | 2021 | 51732 | 0.02 | Why? |
| Internet | 1 | 2020 | 6204 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2021 | 17020 | 0.01 | Why? |
| Algorithms | 1 | 2019 | 7346 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 11367 | 0.01 | Why? |
| Cytokines | 1 | 2021 | 15010 | 0.01 | Why? |
| Prognosis | 1 | 2021 | 32490 | 0.01 | Why? |
| Hospital Mortality | 1 | 2021 | 22087 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| Depression | 1 | 2020 | 14116 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.01 | Why? |
| Infant, Newborn | 1 | 2017 | 23105 | 0.01 | Why? |
| Anxiety | 1 | 2020 | 17311 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.01 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.01 | Why? |
| Infant | 1 | 2017 | 30274 | 0.01 | Why? |
| Child, Preschool | 1 | 2017 | 36283 | 0.01 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2019 | 53120 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.01 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.00 | Why? |
Goss's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(126)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(81)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_